Who are the best — and worst — among the ma­jor phar­mas at de­vel­op­ing drugs for the poor?

A new re­port out to­day cites the he­roes — and ze­roes — among ma­jor phar­ma com­pa­nies when it comes to do­ing drug R&D for the world’s poor.

The non-prof­it Ac­cess to Med­i­cine Foun­da­tion’s an­nu­al R&D re­port cites 5 com­pa­nies for han­dling close to two-thirds of all the pri­or­i­ty R&D work need­ed for un­der-served ar­eas of the world. They’re led by Glax­o­SmithK­line, which has come out on top for 6 years run­ning af­ter mak­ing this field a top pri­or­i­ty for the com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER